Do Hung 4
4 · AMICUS THERAPEUTICS, INC. · Filed Oct 13, 2020
Insider Transaction Report
Form 4
Do Hung
Sr Vice President Discovery
Transactions
- Exercise/Conversion
Common Stock
2020-10-09$9.03/sh+75,000$677,250→ 714,507 total - Sale
Common Stock
2020-10-09$15.03/sh−193,700$2,911,272→ 520,807 total - Exercise/Conversion
Stock Options (right to buy)
2020-10-09−75,000→ 0 totalExercise: $12.28Exp: 2025-06-01→ Common Stock (75,000 underlying) - Exercise/Conversion
Common Stock
2020-10-09$8.61/sh+43,700$376,257→ 564,507 total - Exercise/Conversion
Common Stock
2020-10-09$12.28/sh+75,000$921,000→ 639,507 total - Exercise/Conversion
Stock Options (right to buy)
2020-10-09−43,700→ 0 totalExercise: $8.61Exp: 2025-01-02→ Common Stock (43,700 underlying) - Exercise/Conversion
Stock Options (right to buy)
2020-10-09−75,000→ 0 totalExercise: $9.03Exp: 2026-01-04→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.14 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]All of the options were fully vested and exercisable as of October 9, 2020.